Abbott's CardioMEMS sensor will now be available to patients with chronic heart failure through the NHS, as per NICE's ...
Investors have seemingly homed in on flat sales in the Watchman and electrophysiology segments of Boston’s cardio portfolio, prompting a stock fall.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results